Literature DB >> 30662007

CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway.

Yun Li1, Ping Yang1, Lei Zhao1, Yao Chen1, Xiaoyu Zhang1, Shu Zeng1, Li Wei1, Zac Varghese2, John F Moorhead2, Yaxi Chen3, Xiong Z Ruan4.   

Abstract

Fatty acid translocase cluster of differentiation (CD36) is a multifunctional membrane protein that facilitates the uptake of long-chain fatty acids. Lipophagy is autophagic degradation of lipid droplets. Accumulating evidence suggests that CD36 is involved in the regulation of intracellular signal transduction that modulates fatty acid storage or usage. However, little is known about the relationship between CD36 and lipophagy. In this study, we found that increased CD36 expression was coupled with decreased autophagy in the livers of mice treated with a high-fat diet. Overexpressing CD36 in HepG2 and Huh7 cells inhibited autophagy, while knocking down CD36 expression induced autophagy due to the increased autophagosome formation in autophagic flux. Meanwhile, knockout of CD36 in mice increased autophagy, while the reconstruction of CD36 expression in CD36-knockout mice reduced autophagy. CD36 knockdown in HepG2 cells increased lipophagy and β-oxidation, which contributed to improving lipid accumulation. In addition, CD36 expression regulated autophagy through the AMPK pathway, with phosphorylation of ULK1/Beclin1 also involved in the process. These findings suggest that CD36 is a negative regulator of autophagy, and the induction of lipophagy by ameliorating CD36 expression can be a potential therapeutic strategy for the treatment of fatty liver diseases through attenuating lipid overaccumulation.
Copyright © 2019 Li et al.

Entities:  

Keywords:  adenosine monophosphate-activated protein kinase; autophagy; cluster of differentiation 36; hepatic steatosis; lipid droplets; β-oxidation

Mesh:

Substances:

Year:  2019        PMID: 30662007      PMCID: PMC6446711          DOI: 10.1194/jlr.M090969

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

1.  FoxO transcription factors promote autophagy in cardiomyocytes.

Authors:  Arunima Sengupta; Jeffery D Molkentin; Katherine E Yutzey
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

Review 2.  Eaten alive: a history of macroautophagy.

Authors:  Zhifen Yang; Daniel J Klionsky
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

3.  Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

Authors:  Ling Yang; Ping Li; Suneng Fu; Ediz S Calay; Gökhan S Hotamisligil
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

Review 4.  Glycogen autophagy.

Authors:  Othon B Kotoulas; Stefanos A Kalamidas; Dimitrios J Kondomerkos
Journal:  Microsc Res Tech       Date:  2004-05-01       Impact factor: 2.769

Review 5.  CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

6.  The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function.

Authors:  Sarah J Hoosdally; Edward J Andress; Carol Wooding; Catherine A Martin; Kenneth J Linton
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

7.  LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.

Authors:  Angela Woods; Stephen R Johnstone; Kristina Dickerson; Fiona C Leiper; Lee G D Fryer; Dietbert Neumann; Uwe Schlattner; Theo Wallimann; Marian Carlson; David Carling
Journal:  Curr Biol       Date:  2003-11-11       Impact factor: 10.834

8.  Autophagy regulates lipid metabolism.

Authors:  Rajat Singh; Susmita Kaushik; Yongjun Wang; Youqing Xiang; Inna Novak; Masaaki Komatsu; Keiji Tanaka; Ana Maria Cuervo; Mark J Czaja
Journal:  Nature       Date:  2009-04-01       Impact factor: 49.962

9.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

Authors:  Angela Woods; Kristina Dickerson; Richard Heath; Seung-Pyo Hong; Milica Momcilovic; Stephen R Johnstone; Marian Carlson; David Carling
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

10.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

Authors:  Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  40 in total

1.  Regulation of lipophagy in NAFLD by cellular metabolism and CD36.

Authors:  Dmitri Samovski; Nada A Abumrad
Journal:  J Lipid Res       Date:  2019-02-28       Impact factor: 5.922

2.  CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption.

Authors:  Lide Tao; Xiangmin Ding; Lele Yan; Guangcai Xu; Peijian Zhang; Anlai Ji; Lihong Zhang
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

3.  Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction.

Authors:  Junju Zou; Xiaotao Zhou; Xian Chen; Yuerong Ma; Rong Yu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis.

Authors:  Mengyue You; Fan Wu; Meilin Gao; Mengyue Chen; Shu Zeng; Yang Zhang; Wei Zhao; Danyang Li; Li Wei; Xiong Z Ruan; Yaxi Chen
Journal:  Redox Biol       Date:  2022-10-07       Impact factor: 10.787

5.  CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.

Authors:  Yanjuan Hou; Qian Wang; Baosheng Han; Yiliang Chen; Xi Qiao; Lihua Wang
Journal:  Cell Death Dis       Date:  2021-05-21       Impact factor: 8.469

Review 6.  Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Cardiovasc Toxicol       Date:  2022-01-24       Impact factor: 3.231

Review 7.  Adaptive and maladaptive roles of lipid droplets in health and disease.

Authors:  Jeffrey D Pressly; Margaret Z Gurumani; Javier T Varona Santos; Alessia Fornoni; Sandra Merscher; Hassan Al-Ali
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-02       Impact factor: 4.249

8.  Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19.

Authors:  Ivan Vlasov; Alexandra Panteleeva; Tatiana Usenko; Mikhael Nikolaev; Artem Izumchenko; Elena Gavrilova; Irina Shlyk; Valentina Miroshnikova; Maria Shadrina; Yurii Polushin; Sofya Pchelina; Petr Slonimsky
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

Review 9.  An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease.

Authors:  Ke Pei; Ting Gui; Dongfang Kan; Huichao Feng; Yanqiang Jin; Ying Yang; Qian Zhang; Ziwei Du; Zhibo Gai; Jibiao Wu; Yunlun Li
Journal:  Biomed Res Int       Date:  2020-07-18       Impact factor: 3.411

10.  Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.

Authors:  David R Rawnsley; Abhinav Diwan
Journal:  EBioMedicine       Date:  2020-06-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.